Safety Risks and Side Effects to Be Aware Of Retatrutide's Phase 2 data identified nausea, vomiting, raised resting heart rate, and gallbladder events
Practical steps that may help include: Keeping an updated list of every medication, vitamin, and supplement currently being taken Reporting new symptoms such as dizziness, unusual fatigue, or shakiness promptly to a provider Avoiding starting or stopping other medications without first discussing it with a prescriber Following the prescribed injection schedule consistently, since irregular timing can make side effects harder to track Asking about blood sugar monitoring frequency if insulin or a sulfonylurea is also part of the treatment plan A pattern many providers notice in practice is that patients who are newly combining Semaglutide with insulin often experience mild blood sugar dips in the first two to three weeks, before dosing is fine-tuned, which is part of why early monitoring tends to matter more than people expect

Tirzepatide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis, as further slowing of gastric emptying could exacerbate symptoms
Regarding the specific question of whether Saxenda causes gastroparesis, there is no official established causal link between liraglutide and the development of true gastroparesis
Learn About Stretch Therapy Over 107 five-star reviews on Google